I listened to the Acadia Pharmaceuticals quarterly webcast today and have taken out the following observations.
1.Revenue up 64% from the corresponding quarter last year .
2.The margin on their drug sales are extremely good.
3.The company has an air of confident on what they are doing.
4.Updated sales guidance from a low of $220 million US($305 aussie)and high of $225US($312 aussie).
5.Cash at bank at end of year between $160 and $170mill US.
It will be interesting to see what the market in the US thinks about the update tonite.My guess is that they will do a capital raise very soon based on the above as the window for a cap raise closes up towards the end of the year.
Acadia Pharmaceuticals quarterly
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.25 |
Change
0.600(3.22%) |
Mkt cap ! $2.458B | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.33 | $18.78 | $7.039M | 366.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 638 | $19.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.35 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.24 |
Change
0.600 ( 3.13 %) |
||||
| Open | High | Low | Volume | ||
| $19.09 | $19.33 | $18.80 | 90782 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| NEU (ASX) Chart |